The Rx Collaborative is the largest pharmacy coalition in the U.S. with over $7B in drug costs.
25% Employers can save up to 25% annually on drug costs
Celebrating 20 years at the forefront of pharmacy
2024 marks the 20-year anniversary of WTW’s Rx Collaborative. Continuing to disrupt the marketplace and push for transparency and savings for employer plan sponsors.
We represent over 428 employers with approximately $7 billion in drug spend and 5.3 million members. Our collective purchasing power and expertise enable us to provide you with financial savings, transparency in pricing, pharmacy benefit manager (PBM) oversight and innovative programs and services unsurpassed in today's marketplace.
The Rx Collaborative offers arrangements with four premier PBMs.
With our highly competitive deal terms and cutting-edge clinical and program management, you can achieve significant savings that will immediately impact your bottom line.
If your company has more than 1,000 employees and is eligible for a PBM contract renewal, contact us at RxCollaborative@wtwco.com for a free Rx Collaborative savings analysis. If your company has fewer than 1,000 employees, please visit our Attune Rx page.
| Title | File Type | File Size |
|---|---|---|
| Rx Collaborative 2023 Annual Report to Employers | 4 MB | |
| Rx Collaborative overview | .2 MB |
Delivering solutions and innovations to employers to meet market challenges and needs.
2004
Challenge: Traditional PBM pricing model made it difficult to understand the true cost of drugs.
Innovation: Launched the RxC
2006
Challenge: Employers wanted a better understanding of costs through data and the ability to audit.
Innovation: Added services and features to address employer needs and add more value
2007
Challenge: PBMs formulary had limited focus on lower net cost generic drugs.
Innovation: Formed the Towers Watson Reference Formulary and Pharmacy and Therapeutics Committee
2009
Challenge: Specialty drug costs were growing and becoming a larger portion of drug spend. PBM contract pricing was becoming stale due to broad market pricing improvements.
Innovation: Developed RxC specialty drug list
Added annual market checks with price improvements
2012
Challenge: With consolidation in the PBM space, employers needed additional vendor choice.
Innovation: Added a second PBM partner CVS Caremark
2017
Challenge: Employers needed vendor options other than the two largest PBMs.
Innovation: Added a third PBM partner Optum Rx
2022
Challenge: Employers needed to control specialty spend with flexibility to carve-out from their PBM.
Employers needed mid-market and carve-in solutions.
Innovation: Added a fourth PBM partner Capital Rx
Launched a mid-market carve-out solution, Attune Rx, through a partnership with RxBenefits
2023
Challenge: Employers needed to control specialty spend with flexibility to carve-out from their PBM.
Employers needed mid-market and carve-in solutions.
Innovation: Launched a carve-in solution, ConnectMed Rx, through a partnership with Anthem/Carelon
A PBM is an organization that manages pharmaceutical benefits for employers, managed care organizations or other medical providers. PBM activities may include all or some of the following:
A pharmacy carve-out pharmacy arrangement is when pharmacy benefits are separated from medical benefits and are managed outside of an organization’s primary medical health plan vendor. This approach is self-insured, and an employer works directly with a PBM to administer and manage the pharmacy benefits.
A pharmacy benefit group purchasing employer coalition leverages their members’ combined purchasing power to obtain maximum discounts from their PBM vendor partners for all its members. The group’s collective buying power far exceeds what any one company can generate on its own and can provide savings by being a part of the coalition. In addition, the combined size leads to better account management and services. What differentiates the Rx Collaborative in the market are the superior services and expertise available to its members.
